主页 > 生命科学 >

【medical-news】FDA批准扶他林乳胶用于骨性关节炎

FDA OKs Voltaren Gel for Osteoarthritis
Voltaren Gel Is 1st Prescription Skin Gel for Osteoarthritis Joint Pain

Oct. 23, 2007 -- The FDA has approved Voltaren Gel, the first prescription skin gel to treat osteoarthritis joint pain.

Voltaren Gel contains diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID) that's also in oral Voltaren. The gel can be applied to joints that hurt because of osteoarthritis.

Osteoarthritis is the most common form of arthritis. It happens when the cartilage in joints breaks down and wears away.

The FDA approved Voltaren Gel based on studies that together included more than 900 patients with knee or hand osteoarthritis, according to Novartis, which makes Voltaren Gel.

Voltaren Gel was shown to cut pain in knee and hand osteoarthritis, states Novartis.

It wasn't evaluated for use on joints of the spine, hip, or shoulder, according to the drug's label.

The most common side effects reported in clinical trials of Voltaren Gel were skin reactions; 7% of patients had reactions on the place where the gel was applied.

http://www.webmd.com/osteoarthritis/news/20071023/fda-oks-voltaren-gel-for-osteoarthritis 本人已认领该文编译,48小时后若未提交译文,请其他战友自由认领。 FDA OKs Voltaren Gel for Osteoarthritis
Voltaren Gel Is 1st Prescription Skin Gel for Osteoarthritis Joint Pain
FDA批准扶他林乳胶剂用于骨性关节炎
扶他林乳胶剂是第一种用于治疗骨性关节炎的处方式皮肤用乳胶剂。
Oct. 23, 2007 -- The FDA has approved Voltaren Gel, the first prescription skin gel to treat osteoarthritis joint pain.
FDA已经批准了第一种处方式皮肤用乳胶剂即扶他林乳胶用于治疗骨性关节炎疼痛。
2007, 10, 23
Voltaren Gel contains diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID) that's also in oral Voltaren. The gel can be applied to joints that hurt because of osteoarthritis.
扶他林乳胶剂同扶他林口服制剂一样含有一种非甾体抗炎药(NSAID)双氯芬酸钠,所以该乳胶剂可用于骨性关节炎引起的疼痛。
Osteoarthritis is the most common form of arthritis. It happens when the cartilage in joints breaks down and wears away.
骨性关节炎是一种最常见的关节炎,常发于软骨关节损伤或磨损。
The FDA approved Voltaren Gel based on studies that together included more than 900 patients with knee or hand osteoarthritis, according to Novartis, which makes Voltaren Gel.
据扶他林乳胶剂的生产商诺华公司声称,FDA是在其对900多名患者的膝和手关节炎的研究基础之上批准扶他林乳胶剂的。
Voltaren Gel was shown to cut pain in knee and hand osteoarthritis, states Novartis.
研究结果显示,扶他林乳胶剂对膝盖和手性关节疼痛有阻断作用。
It wasn't evaluated for use on joints of the spine, hip, or shoulder, according to the drug's label.
但根据该药标签所示,扶他林乳胶剂还没被证明可用于脊柱骨关节、髋关节及肩关节炎的治疗。
The most common side effects reported in clinical trials of Voltaren Gel were skin reactions; 7% of patients had reactions on the place where the gel was applied.
扶他林乳胶剂的临床试验报道指出,其最常见的副作用是皮肤反应:有7%的患者在乳胶剂使用处产生过反应。
http://www.webmd.com/osteoarthritis/news/20071023/fda-oks-voltaren-gel-for-osteoarthritis

编译

FDA批准扶他林乳胶剂用于骨性关节炎

扶他林乳胶剂是第一种用于治疗骨性关节炎的处方式皮肤用乳胶剂。

FDA已经批准了第一种处方式皮肤用乳胶剂即扶他林乳胶用于治疗骨性关节炎疼痛。
2007年10月23日

扶他林乳胶剂同扶他林口服制剂一样含有一种非甾体抗炎药(NSAID)双氯芬酸钠,所以该乳胶剂可用于骨性关节炎引起的疼痛。骨性关节炎是一种最常见的关节炎,常发于软骨关节损伤或磨损。据扶他林乳胶剂的生产商诺华公司声称,FDA是在其对900多名患者的膝和手关节炎的研究基础之上批准扶他林乳胶剂的。研究结果显示,扶他林乳胶剂对膝盖和手性关节疼痛有阻断作用。但根据该药标签所示,扶他林乳胶剂还没被证明可用于脊柱骨关节、髋关节及肩关节炎的治疗。扶他林乳胶剂的临床试验报道指出,其最常见的副作用是皮肤反应:有7%的患者在乳胶剂使用处产生过反应。
http://www.webmd.com/osteoarthritis/news/20071023/fda-oks-voltaren-gel-for-osteoarthritis

阅读本文的人还阅读:

【medical-news】Matrilin-3基

【medical-news】类风湿性关

【medical-news】转基因真菌

【文摘发布】让脂肪肝可

【药学】关节炎药物治疗

作者:admin@医学,生命科学    2011-05-24 17:14
医学,生命科学网